A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma

被引:11
|
作者
Zhao, Kai [1 ]
Li, Xiangyu [1 ]
Shi, Yuanxin [1 ]
Lu, Yun [1 ]
Qiu, Peng [1 ]
Deng, Zhengdong [1 ]
Yao, Wei [2 ]
Wang, Jianming [1 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Biliary & Pancreat Surg,Canc Res Ctr, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Affiliated Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China
[3] Wuhan Univ Sci & Technol, Affiliated Tianyou Hosp, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
pancreatic adenocarcinoma; pyroptosis; lncRNAs; prognosis; tumor immune microenvironment; immunotherapy; CELL-DEATH; CANCER STATISTICS; PROMOTES; PATHWAY;
D O I
10.3389/fgene.2022.899496
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Globally, pancreatic adenocarcinoma (PAAD) is a common and highly devastating gastrointestinal malignancy that seriously threatens human health. Pyroptosis refers to an emerging form of programmed cell death that has been discovered in recent years, and studies have demonstrated that long non-coding RNA (lncRNA) may act as a moderator in the pyroptosis process of cancer cells. However, relevant explorations about lncRNAs and pyroptosis are still insufficient in PAAD. Therefore, our research is designed to make a comprehensive analysis of the potential values of pyroptosis-related lncRNAs in PAAD.Methods: By integrating the RNA-sequencing, somatic mutation, and copy number variation (CNV) datasets, as well as the clinicopathological features, we established and validated a risk signature based on pyroptosis-related lncRNAs, and comprehensively analyzed its clinical significance and the potential connection with the tumor immune microenvironment (TIME).Consequences: The genetic variation landscape displayed that the somatic mutations were rare while CNV changes were general and mainly concentrated on copy number amplification of these 52 pyroptosis-related genes. Subsequently, a risk signature consisting of 10 lncRNAs (TRAF3IP2-AS1, LINC00519, LINC01133, LINC02251, AC005332.6, AL590787.1, AC090114.2, TRPC7-AS1, MIR223HG, and MIR3142HG) was constructed and patients were divided into different subgroups according to the median risk score; patients with high-risk scores presented worse outcomes compared to those with low-risk scores in the training, testing, and entire cohorts. Furthermore, patients at low-risk scores possessed a higher infiltration abundance of immune cells compared with high-risk patients, which was consistent with the expression levels of lncRNAs between the high/low-risk groups. Drug sensitivity analysis showed that low-risk scores were related to anti-cancer agents like AICAR and Axitinib, whereas high-risk scores were connected with certain drugs such as AUY922. These results demonstrated that our risk signature could be used for prognosis prediction; additionally, it was also related to the TIME that might act as a potential indicator to instruct immunotherapeutic strategies.Conclusion: This work explored the significance of the risk model constructed by pyroptosis-related lncRNAs in prognosis prediction and its internal link with the immune microenvironment of PAAD. The results are expected to assist in the diagnosis, prognostic assessment, and management of patients with PAAD.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer
    Zhang, Guian
    Luo, Yong
    Dong, Weimin
    Zhong, Weide
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [42] Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment
    Xu, Zihan
    Zhao, Yujie
    Zhang, Yong
    Liu, Xiaowei
    Song, Linlin
    Chen, Meixu
    Xiao, Guixiu
    Ma, Xuelei
    Shi, Hubing
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] Pyroptosis-Related lncRNAs Predict the Prognosis and Immune Response in Patients With Breast Cancer
    Yang, Xia
    Weng, Xin
    Yang, Yajie
    Jiang, ZhiNong
    FRONTIERS IN GENETICS, 2022, 12
  • [44] Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma
    Fang, Guoxu
    Zhang, Qinghua
    Fan, Jianhui
    Li, Haitao
    Ding, Zongren
    Fu, Jun
    Wu, Yijun
    Zeng, Yongyi
    Liu, Jingfeng
    BMC CANCER, 2022, 22 (01)
  • [45] A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma
    Zhu, Wenying
    Ye, Zhipeng
    Chen, Ling
    Liang, Haifeng
    Cai, Qian
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 101
  • [46] Identification of a Pyroptosis-Related Gene Signature for Predicting the Immune Status and Prognosis in Lung Adenocarcinoma
    Gong, Zetian
    Li, Qifan
    Yang, Jian
    Zhang, Pengpeng
    Sun, Wei
    Ren, Qianhe
    Tang, Junjie
    Wang, Wei
    Gong, Hui
    Li, Jun
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [47] The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia
    Sha, Yeqin
    Jiang, Rui
    Miao, Yi
    Qin, Shuchao
    Wu, Wei
    Xia, Yi
    Wang, Li
    Fan, Lei
    Jin, Hui
    Xu, Wei
    Li, Jianyong
    Zhu, Huayuan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma
    Cui, Guoliang
    Liu, Jinhui
    Wang, Can
    Gu, Renjun
    Wang, Manli
    Sun, Zhiguang
    Wei, Fei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [49] Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma
    Liu, Jichang
    Liu, Qiang
    Shen, Hongchang
    Liu, Yong
    Wang, Yadong
    Wang, Guanghui
    Du, Jiajun
    FRONTIERS IN GENETICS, 2022, 13
  • [50] Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma
    Tan, Yuying
    Lu, Liqing
    Liang, Xujun
    Chen, Yongheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)